No association between antiepileptic drug use and dementia
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
List view / Grid view
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
A collaboration between Brigham and Women's Hospital and Vanderbilt University Medical Center looks to advance the application of AI in health...
Draft guidance has been released to offer advice on the new CDER program for the recognition of voluntary consensus standards relating to pharma quality...
Innovations in drug manufacturing could result in higher quality drugs at less of the cost, and the FDA is willing to help facilitate this development...
The SMC has approved a drug, called rivaroxaban, that targets Factor Xa to treat those with coronary artery disease (CAD)...
A Phase III trial looks to treat dry eye syndrome using a sterile, preservative-free eye drop formulation that has thymosin beta 4 as its active ingredient...
Health Canada has issued a Notice of Compliance with conditions for the first oral drug for acute myeloid leukaemia, a rapidly progressing condition...
The falsified medicines directive (FMD) has finally kicked in, but how will the UK supply chain be affected, and how will pharmacies and hospitals cope?
Researchers have identified a method of improving the performance of infrared imaging techniques which could be useful in medical applications...
NICE in the UK and its counterpart - the Canadian Agency for Drugs and Technology in Health have collaborated to offer parallel scientific advice...
The pilot project will test innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the US...
A compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
Innovations across drug delivery devices, dosage packaging, and materials and components bestowed in the Exhibitor Innovation Category...
Wickham Laboratories Ltd is delighted to announce our most recent technical article on, “microbiological considerations in cleanroom validation”, which has been featured in European Pharmaceutical Review’s December 2018 issue...
Findings of two phase III, double-blind, randomised clinical trials comparing omadacycline with standard antibiotics have been published in the New England Journal of Medicine